Riley Antony A
Insider CIK 1339375 · FBRX Chief Financial Officer · KRYS Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 90,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,999 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,999 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 14,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 323,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 1,700 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 22,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 750 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 60,000 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,976 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 421 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | U Tender | 2026-08-27 | 2026-08-27 | 42,600 | — | $0 | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,976 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 60,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 750 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 22,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 90,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 323,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 14,000 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,999 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 1,700 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 2,999 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | D To issuer deriv | 2026-08-27 | 2026-08-27 | 421 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | U Tender | 2026-08-27 | 2026-08-27 | 42,600 | — | — | 0 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2026-07-01 | 2026-07-06 | 375 | — | $0 | 750 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2026-07-01 | 2026-07-06 | 375 | — | $0 | 42,734 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2026-07-01 | 2026-07-06 | 134 | $21.32 | $2.9K | 42,600 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2026-06-16 | 2026-06-17 | 22,000 | — | $0 | 22,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2026-04-01 | 2026-04-03 | 375 | — | $0 | 1,125 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2026-04-01 | 2026-04-03 | 134 | $24.86 | $3.3K | 41,982 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2026-04-01 | 2026-04-03 | 375 | — | $0 | 42,116 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2026-01-12 | 2026-01-13 | 60,000 | — | $0 | 60,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2026-01-12 | 2026-01-13 | 90,000 | — | $0 | 90,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2026-01-01 | 2026-01-02 | 375 | — | $0 | 1,500 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2026-01-01 | 2026-01-02 | 154 | $27.27 | $4.2K | 41,741 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2026-01-01 | 2026-01-02 | 375 | — | $0 | 41,895 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2025-12-30 | 2026-01-02 | 9,680 | $26.33 | $254.9K | 41,520 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2025-10-01 | 2025-10-02 | 375 | — | $0 | 1,875 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2025-10-01 | 2025-10-02 | 375 | — | $0 | 31,974 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2025-10-01 | 2025-10-02 | 134 | $14.52 | $1.9K | 31,840 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2025-07-01 | 2025-07-03 | 375 | — | $0 | 2,250 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2025-07-01 | 2025-07-03 | 134 | $12.44 | $1.7K | 31,599 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2025-07-01 | 2025-07-03 | 375 | — | $0 | 31,733 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2025-04-01 | 2025-04-02 | 375 | — | $0 | 2,625 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2025-04-01 | 2025-04-02 | 154 | $7.43 | $1.1K | 31,218 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2025-04-01 | 2025-04-02 | 375 | — | $0 | 31,372 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2025-03-20 | 2025-03-21 | 323,000 | — | $0 | 323,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2025-01-01 | 2025-01-02 | 375 | — | $0 | 3,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2025-01-01 | 2025-01-02 | 375 | — | $0 | 31,151 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2025-01-01 | 2025-01-02 | 154 | $22.71 | $3.5K | 30,997 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2024-11-21 | 2024-11-22 | 22,514 | $5.55 | $125.0K | 30,776 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2024-10-01 | 2024-10-02 | 375 | — | $0 | 3,375 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2024-10-01 | 2024-10-02 | 133 | $5.16 | $686 | 8,262 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2024-10-01 | 2024-10-02 | 375 | — | $0 | 8,395 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2024-07-01 | 2024-07-03 | 9,375 | — | $0 | 93,750 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2024-07-01 | 2024-07-03 | 9,375 | — | $0 | 203,849 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2024-07-01 | 2024-07-03 | 3,345 | $0.55 | $1.8K | 200,504 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2024-04-01 | 2024-04-02 | 9,375 | — | $0 | 103,125 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2024-04-01 | 2024-04-02 | 3,345 | $0.71 | $2.4K | 194,474 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2024-04-01 | 2024-04-02 | 9,375 | — | $0 | 197,819 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2024-03-21 | 2024-03-25 | 350,000 | — | $0 | 350,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2024-01-01 | 2024-01-03 | 9,375 | — | $0 | 112,500 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2024-01-01 | 2024-01-03 | 9,375 | — | $0 | 192,285 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2024-01-01 | 2024-01-03 | 3,841 | $0.82 | $3.1K | 188,444 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2023-10-01 | 2023-10-03 | 9,375 | — | $0 | 121,875 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2023-10-01 | 2023-10-03 | 9,375 | — | $0 | 186,151 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2023-10-01 | 2023-10-03 | 3,241 | $0.66 | $2.1K | 182,910 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award | 2023-07-31 | 2023-08-02 | 148,514 | $1.01 | $150.0K | 176,776 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2023-07-01 | 2023-07-05 | 9,375 | — | $0 | 131,250 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2023-07-01 | 2023-07-05 | 9,375 | — | $0 | 28,003 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2023-07-01 | 2023-07-05 | 3,241 | $1.04 | $3.4K | 24,762 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise deriv | 2023-04-01 | 2023-04-04 | 9,375 | — | $0 | 140,625 | SEC↗ |
| FBRX Forte Biosciences, Inc. | F Tax w/h | 2023-04-01 | 2023-04-04 | 3,241 | $1.01 | $3.3K | 18,628 | SEC↗ |
| FBRX Forte Biosciences, Inc. | M Exercise | 2023-04-01 | 2023-04-04 | 9,375 | — | $0 | 21,869 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2023-02-25 | 2023-02-27 | 150,000 | — | $0 | 150,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2022-01-17 | 2022-01-18 | 75,000 | — | $0 | 75,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | S Sale | 2021-09-07 | 2021-09-07 | 3,516 | $4.27 | $15.0K | 11,065 | SEC↗ |
| FBRX Forte Biosciences, Inc. | S Sale | 2021-09-07 | 2021-09-07 | 21,484 | $4.24 | $91.1K | 14,581 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2021-04-09 | 2021-04-13 | 42,500 | — | $0 | 42,500 | SEC↗ |
| FBRX Forte Biosciences, Inc. | A Award deriv | 2020-06-30 | 2020-06-30 | 75,000 | — | $0 | 75,000 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2020-06-29 | 2020-06-30 | 2,000 | $14.11 | $28.2K | 36,065 | SEC↗ |
| FBRX Forte Biosciences, Inc. | P Buy | 2020-06-26 | 2020-06-30 | 4,700 | $14.52 | $68.2K | 34,065 | SEC↗ |
| KRYS Krystal Biotech, Inc. | M Exercise deriv | 2019-11-19 | 2019-11-21 | 6,250 | — | $0 | 18,750 | SEC↗ |
| KRYS Krystal Biotech, Inc. | M Exercise | 2019-11-19 | 2019-11-21 | 6,250 | $9.85 | $61.6K | 9,050 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2019-06-01 | 2019-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2019-03-22 | 2019-03-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KRYS Krystal Biotech, Inc. | P Buy | 2018-05-22 | 2018-05-24 | 2,800 | $10.75 | $30.1K | 2,800 | SEC↗ |
| KRYS Krystal Biotech, Inc. | A Award deriv | 2018-03-08 | 2018-05-24 | 25,000 | — | $0 | 25,000 | SEC↗ |